Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received, on June 3rd, 2020, clearance from the U.S. FDA for its recently submitted Investigational New Drug (IND) application for its planned multinational Phase 2b/3 study of its re-purposed drug NP-120 (Ifenprodil) as a potential therapeutic…
Read More
Public health authorities around the world are facing a significant challenge: ensuring a large enough supply of reagents to scale-up diagnostic testing for COVID-19. Researchers at UBC, Canada’s Michael Smith Genome Sciences Centre at BC Cancer (GSC) and the BC Centre for Disease Control (BCCDC) are working to develop new non-proprietary reagents to support testing in British Columbia. UBC geneticist…
Read More
Collaborative and interdisciplinary research is integral to scientific advancement. Too often, silos form around avenues of inquiry (and sometimes entire fields of study) limiting exposure to bright and enthusiastic minds who are ready to innovate and make a difference. It’s no small leap to see this as scientific advancement shooting itself in the foot. This is why the SBME was…
Read More
Cardiac complications and arrhythmias, which include fast, slow and irregular heartbeats, are major causes of death in patients with diabetes-related hyperglycemia. The arrhythmias are a consequence of high blood sugar levels called hyperglycemia, which radically affects the normal function of proteins in the heart. SFU researchers Peter Ruben, Mohamed Fouda and Reza Ghovanloo have new evidence that Cannabidiol (CBD), the…
Read More
Humans aren’t the only ones fighting a pandemic right now. Honey bees are also at risk, under attack by a parasite that is killing millions of colonies around the world. Much like people, honey bees are employing techniques like hygiene and social distancing to survive. But parasites are just one of several threats to the world’s honey bees. And scientists…
Read More
In order to fast-track solutions to COVID-19 and mitigate its adverse economic impacts, Mitacs and Innovate BC are partnering to support business in the province of British Columbia. Innovate BC is investing $375,000 towards 100 Mitacs internships for COVID-19-specific projects. The funding infusion from Innovate BC coupled with Mitacs’s leveraged funds offsets the standard company-partner contribution towards the intern’s stipend…
Read More
American pharmaceutical giant Eli Lilly and Co. (NYSE:LLY) confirmed Monday (June 1) human patients have been dosed in the world’s first study of a potential antibody treatment against COVID-19. The treatment known as LY-CoV555 was developed as part of a collaboration between Lilly and Vancouver-based AbCellera Biologics Inc. The federal government has earmarked $175 million for AbCellera as it pursues…
Read More
Genome BC is pleased to announce a further investment of $500,000 in addition to $1 million last year to LightIntegra Technology (LIT). LIT has developed the first analyzer to provide a routine test for platelet activation status. A Vancouver based medical device company, LIT is focused on improving the quality of and providing the necessary level of blood platelets in…
Read More
Universities are not the only public institutions where highly educated scientists can pursue a fruitful career — these specific skills, abilities, and knowledge are also direly needed in government positions to develop and introduce policies. Does that sound like the way you would like to make a difference? We wanted to learn more about scientific careers in government agencies, thus,…
Read More